Arbutus Biopharma Corporation
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $144.4M
Liabilities Breakdown FY2023
Total Liabilities: $38.4M
Asset Breakdown
Total Assets: $144.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $26.3M | 18.2% |
| Accounts Receivable | $1.8M | 1.2% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.7M | 3.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $111.7M | 77.3% |
Liabilities Breakdown
Total Liabilities: $38.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 8.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $35.2M | 91.6% |